The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from infectious diseases. GloPID-R is intended to be a means for facilitating communication and collaboration between its member bodies, as opposed to a funding or disaster response entity. Its secretariat is funded by the European Union through its Horizon 2020 initiative.
History GloPID-R was launched in February 2013 in Brussels, Belgium on the recommendation of the Heads of International Research Organizations (HIROs).
On February 11–12, 2020, GloPID-R co-hosted an event with the World Health Organization's R&D Blueprint called “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap”. Participants in this conference identified a number of key research priorities which served as the basis on which funding decisions were made in response to the COVID-19 pandemic.
__TOC__
Membership GloPID-R's membership is made up of national research funding agencies, academic research institutes and philanthropic organizations. The World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and European and Developing Countries Clinical Trials Partnership (EDCCTP) serve as observers.
, GloPID-R's member organizations were as follows: +Members and RepresentativesOrganizationRepresentativeNationAcademy of Scientific Research & TechnologyAmr RadwanEgyptAfrican Academy of SciencesThomas KariukiKenyaANRS Emerging Infectious DiseasesYazdan YazdanpanahFranceBill & Melinda Gates FoundationDavid W. VaughnUnited StatesButantan InstituteAlexander PreciosoBrazilCanadian Institutes of Health ResearchCharu KaushicCanadaCarlos III Health InstituteTomás López-PeñaSpainCoalition for Epidemic Preparedness InnovationsRichard Hatchett, Frederik KristensenGlobalUnited States Department of Health and Human ServicesChris HassellUnited StatesESSENCE on Health Research InitiativeGarry AslanyanGlobalEuropean and Developing Countries Clinical Trials PartnershipPauline BeattieGlobalEuropean CommissionBarbara KerstiensEuropean UnionEuropean Research Infrastructure on Highly Pathogenic AgentsJonathan EwbankEuropean UnionInstituto FiocruzMarco KriegerBrazilNational Research and Innovation Fund for Development (FONRID)Hamidou H. TambouraBurkina FasoFund for Science, Technology and Innovation (FONSTI)Annette OuattaraIvory CoastForeign, Commonwealth and Development OfficeJo MulliganUnited KingdomGavi, the Vaccine AllianceMarta Tufet-BayonaGlobalFederal Ministry of Education and ResearchManuela RehtanzGermanyGlobal Outbreak Alert and Response NetworkGail CarsonGlobalInternational Development Research CentreSamiran PandaCanadaJapan Agency for Medical Research and DevelopmentShoji MiyagawaJapanMedical Research Council (MRC)Anna KinseyUnited KingdomItalian Ministry of HealthGaetano GuglielmiItalyNational Council for Science and TechnologyEugène MutimuraRwandaNational Council of Science and Technology (CONACYT)Juan José SerratoMexicoNational Health and Medical Research CouncilAnne KelsoAustraliaThai National Institute of HealthAree ThattiyaphongThailandNational Research Foundation of KoreaChoong-Min RyuSouth KoreaNetherlands Organisation for Health Research and Development (ZONMW)Suzanne VerverNetherlandsPasteur NetworkNadia KhelefFranceResearch Council of NorwayThomas HansteenNorwaySão Paulo Research FoundationRui MacielBrazilSecretariat of Government of Science, Technology and Productive InnovationDiego GaleanoArgentinaSouth African Medical Research CouncilJeffrey MphahleleSouth AfricaSwiss National Science FoundationMatthias EggerSwitzerlandDepartment of Health and Social CareLucy ChappellUnited KingdomWellcome TrustJeremy FarrarUnited KingdomWorld Health OrganizationAna-Maria Henao-RestrepoGlobal
References
External links http://www.glopid-r.org/